LBP and hepatocellular carcinoma: The LBP/pCas9 complex successively resulted in genome editing in HCC, where the knockout of the survivin gene led to apoptosis and proliferation inhibition of tumor cells in vitro, and the gene-editing efficiency was 26.4% in orthotopic HCC mouse models.